tiprankstipranks
Trending News
More News >
Integer Holdings (ITGR)
:ITGR

Integer Holdings (ITGR) AI Stock Analysis

Compare
121 Followers

Top Page

IT

Integer Holdings

(NYSE:ITGR)

70Outperform
Integer Holdings shows robust financial performance with strong revenue growth and strategic acquisitions. However, technical analysis indicates weak market momentum and high P/E ratio implies overvaluation. The overall score reflects these strengths and weaknesses, with positive corporate events and earnings call highlighting strategic initiatives and growth potential.
Positive Factors
Debt Management
Integer was able to knock off nearly 2% in average interest rate on its borrowings, to 2.9% from 4.8% previously, boosting the bottom line going forward.
Financial Performance
Integer Holdings reported better-than-expected financial results for its 1Q25, including revenues of $437.4 million, up 7.3% year-over-year.
Product Launches
New product launches should drive significant growth in the C&V sector.
Negative Factors
Leverage
Integer’s leverage ratio jumped to 3.3x from 2.6x at the start of the year, indicating increased financial risk.
Sales Performance
CRM & Neuromod sales underperformed expectations, creating a potential area of concern for future growth.
Valuation
The price target is being lowered to $140 due to reduced valuation metrics for comparable stocks.

Integer Holdings (ITGR) vs. S&P 500 (SPY)

Integer Holdings Business Overview & Revenue Model

Company DescriptionInteger Holdings Corporation (ITGR) is a leading medical device outsource (MDO) manufacturer, providing innovative, high-quality medical technologies and solutions to the healthcare industry. The company operates primarily in the cardiac, neuromodulation, vascular, orthopedics, and advanced surgical sectors. Its core products include implantable components, sophisticated medical devices, and non-implantable products for a broad array of applications. Integer Holdings serves a global customer base, including leading medical device companies and healthcare providers, by providing end-to-end solutions from design and development to manufacturing and supply chain management.
How the Company Makes MoneyInteger Holdings generates revenue through its comprehensive suite of services that cater to the design, development, and manufacturing needs of medical device companies. The company's key revenue streams include the sale of implantable components, such as batteries and capacitors used in cardiac and neuromodulation devices, as well as the manufacturing of complex catheters and other medical devices. Integer also capitalizes on its engineering and technical expertise to offer value-added services like product testing and regulatory support. Furthermore, the company engages in strategic partnerships and long-term contracts with major medical device firms, which help ensure a steady income stream and foster collaborative innovation.

Integer Holdings Financial Statement Overview

Summary
Integer Holdings shows strong revenue growth and operational efficiency with a robust balance sheet. However, increased leverage requires monitoring, and there is room for margin improvements.
Income Statement
78
Positive
Integer Holdings demonstrates strong revenue growth with a TTM (Trailing-Twelve-Months) increase from the previous year, indicating a healthy growth trajectory. The gross profit margin remains robust, although net profit margins have declined compared to the previous period, suggesting potential efficiency improvements. EBITDA and EBIT margins are solid, reflecting operational strength despite slight fluctuations in net income.
Balance Sheet
72
Positive
The company's balance sheet shows a stable equity ratio, indicating a solid financial foundation with adequate equity backing its assets. The debt-to-equity ratio has increased, suggesting rising leverage which could pose a risk if not managed carefully. Return on equity remains strong, demonstrating effective use of shareholder funds.
Cash Flow
75
Positive
Integer Holdings exhibits consistent operating cash flow, reflecting healthy cash generation from operations. Free cash flow has grown significantly, supporting further investment opportunities. However, the ratio of operating cash flow to net income is slightly lower, implying room for improvement in converting income into cash.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
1.72B1.60B1.38B1.22B1.07B
Gross Profit
459.01M418.29M359.01M336.97M285.71M
EBIT
208.24M167.33M121.33M135.71M120.61M
EBITDA
310.91M256.51M215.40M215.26M207.56M
Net Income Common Stockholders
119.90M90.65M66.38M96.81M77.26M
Balance SheetCash, Cash Equivalents and Short-Term Investments
46.54M23.67M24.27M17.89M49.21M
Total Assets
3.08B2.94B2.79B2.58B2.37B
Total Debt
1.10B1.05B1.01B897.75M777.55M
Net Debt
1.06B1.03B983.41M879.87M728.34M
Total Liabilities
1.46B1.42B1.38B1.23B1.10B
Stockholders Equity
1.62B1.52B1.42B1.35B1.27B
Cash FlowFree Cash Flow
99.60M60.27M41.65M103.20M129.90M
Operating Cash Flow
205.21M180.21M116.38M156.67M181.34M
Investing Cash Flow
-195.41M-163.37M-200.42M-271.00M-56.58M
Financing Cash Flow
13.32M-18.01M92.48M81.99M-88.58M

Integer Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price125.66
Price Trends
50DMA
119.73
Positive
100DMA
128.97
Negative
200DMA
128.29
Negative
Market Momentum
MACD
1.73
Negative
RSI
60.39
Neutral
STOCH
87.42
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ITGR, the sentiment is Positive. The current price of 125.66 is above the 20-day moving average (MA) of 118.71, above the 50-day MA of 119.73, and below the 200-day MA of 128.29, indicating a neutral trend. The MACD of 1.73 indicates Negative momentum. The RSI at 60.39 is Neutral, neither overbought nor oversold. The STOCH value of 87.42 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ITGR.

Integer Holdings Risk Analysis

Integer Holdings disclosed 36 risk factors in its most recent earnings report. Integer Holdings reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Integer Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$4.39B85.118.48%28.49%
70
Outperform
$4.38B59.624.98%7.41%-22.10%
64
Neutral
$4.19B-111.13%20.13%10.05%
54
Neutral
$2.00B32.034.87%8.33%256.54%
54
Neutral
$3.05B-27.62%59.36%19.87%
52
Neutral
$5.35B3.96-42.60%2.86%17.58%1.27%
47
Neutral
$5.01B-20.36%23.92%19.82%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ITGR
Integer Holdings
125.66
13.93
12.47%
GKOS
Glaukos
87.61
-17.40
-16.57%
LIVN
LivaNova
36.78
-25.82
-41.25%
IRTC
Irhythm Technologies
131.12
24.29
22.74%
INSP
Inspire Medical Systems
159.81
-91.15
-36.32%
PRCT
PROCEPT BioRobotics
55.62
-5.81
-9.46%

Integer Holdings Earnings Call Summary

Earnings Call Date:Apr 24, 2025
(Q1-2025)
|
% Change Since: 4.27%|
Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment Positive
The earnings call presented a positive outlook with strong sales and income growth, successful acquisitions, and strategic refinancing. However, challenges such as potential tariff impacts and a slowdown in CRM and neuromodulation sales were noted. Despite these challenges, the overall sentiment is positive due to the company's robust growth and strategic initiatives.
Q1-2025 Updates
Positive Updates
Strong Sales Growth
Integer Holdings Corporation reported a 7% year-over-year increase in sales on a reported basis and 6% on an organic basis in Q1 2025.
Adjusted Operating Income Increase
Adjusted operating income grew by 14% year-over-year, doubling the sales growth rate.
Cardio and Vascular Sales Surge
Sales in the cardio and vascular segment increased by 17% in the first quarter, driven by new product ramps and acquisitions.
Raised Adjusted EPS Outlook
The company raised its adjusted EPS outlook by $0.31, with anticipated growth of 16% to 23% for the full year.
Successful Debt Refinancing
Integer Holdings completed a strategic refinancing that significantly increased the portion of debt fixed at a sub-2% rate, expecting to reduce interest expense by $13 million in 2025.
Tuck-In Acquisitions
Completed acquisitions of Precision Coating and BSI PERILING, expanding service offerings and capabilities.
Negative Updates
Potential Tariff Impact
Estimated tariff impact of $1 to $5 million on adjusted operating income for 2025.
CRM and Neuromodulation Sales Growth Deceleration
Sales in the CRM and neuromodulation segment grew by only 2% in Q1 2025, indicating a slowdown compared to previous years.
Increased Net Total Debt
Net total debt increased to $1.23 billion at the end of Q1 2025, reflecting recent acquisitions and costs associated with the convertible note offering.
Company Guidance
During Integer Holdings Corporation's first quarter 2025 earnings call, the company provided robust guidance for the full year. Sales are projected to grow 8-10% on a reported basis and 6-8% organically. The company anticipates adjusted operating income growth of 11-16%, with an expected impact from tariffs estimated to be $1-5 million. Integer raised its adjusted earnings per share (EPS) outlook by $0.31, forecasting a growth of 16-23%, partially benefiting from a March convertible note offering. The company's first-quarter performance saw sales reach $437 million, reflecting 7% year-over-year growth, with adjusted EBITDA increasing by 14% to $92 million. Integer also completed two tuck-in acquisitions, enhancing its capabilities in differentiated and proprietary coating services. The company expects to maintain its net total debt leverage within the strategic range of 2.5 to 3.5 times EBITDA by year-end.

Integer Holdings Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Integer Holdings Announces Leadership Transition Plan
Positive
Apr 24, 2025

Integer Holdings Corporation announced a leadership transition plan where Joseph Dziedzic will retire as President and CEO on October 24, 2025, with Payman Khales, the current COO, succeeding him. Dziedzic will continue as a Special Advisor until March 31, 2026, to ensure a smooth transition. This change is part of Integer’s strategy to maintain its growth trajectory in high-growth markets by focusing on innovation and operational excellence. The transition is expected to strengthen Integer’s market position and continue its financial objectives of above-market organic sales growth.

Spark’s Take on ITGR Stock

According to Spark, TipRanks’ AI Analyst, ITGR is a Outperform.

Integer Holdings presents a strong financial performance with robust revenue growth and cash flow management, supported by a positive earnings outlook and strategic acquisitions. However, technical indicators suggest weak market momentum, and the high P/E ratio implies the stock is overvalued. The overall score reflects these strengths and weaknesses, positioning Integer as a stable but currently expensive investment in the Medical Devices industry.

To see Spark’s full report on ITGR stock, click here.

Private Placements and FinancingM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Integer Holdings Reports Strong Q1 2025 Performance
Positive
Apr 24, 2025

Integer Holdings Corporation reported a strong start to 2025, with first-quarter sales increasing by 7% to $437 million and a 14% rise in adjusted operating income. Despite a GAAP loss due to debt conversion expenses, the company saw significant growth in its cardio and vascular segment and adjusted net income. Integer completed a $1.0 billion convertible notes offering, which is expected to reduce interest expenses and support future growth, including acquisitions of Precision Coating and VSi Parylene. The company raised its adjusted EPS outlook, reflecting confidence in continued sales and income growth.

Spark’s Take on ITGR Stock

According to Spark, TipRanks’ AI Analyst, ITGR is a Outperform.

Integer Holdings presents a strong financial performance with robust revenue growth and cash flow management, supported by a positive earnings outlook and strategic acquisitions. However, technical indicators suggest weak market momentum, and the high P/E ratio implies the stock is overvalued. The overall score reflects these strengths and weaknesses, positioning Integer as a stable but currently expensive investment in the Medical Devices industry.

To see Spark’s full report on ITGR stock, click here.

Business Operations and StrategyFinancial Disclosures
Integer Holdings Minimizes Impact of New Tariffs
Neutral
Apr 11, 2025

On April 11, 2025, Integer Holdings Corporation announced that the recent tariffs are expected to have an immaterial impact on its 2025 financial results, estimating an effect of $1 to $5 million on full-year adjusted operating income. The company has implemented and planned mitigation actions to address these tariffs, which were announced by the U.S. on April 2, 2025. This announcement reflects the company’s strategic positioning to manage external economic challenges and maintain its operational stability.

Spark’s Take on ITGR Stock

According to Spark, TipRanks’ AI Analyst, ITGR is a Outperform.

Integer Holdings shows solid financial performance, driven by strong revenue and cash flow growth, and a positive earnings call sentiment. However, the stock’s technical indicators suggest caution due to bearish trends, and its high P/E ratio indicates overvaluation. Strategic acquisitions and positive guidance for 2025 contribute positively, but potential tariff impacts and market exit risks present challenges.

To see Spark’s full report on ITGR stock, click here.

Private Placements and FinancingBusiness Operations and Strategy
Integer Holdings Closes $1 Billion Notes Offering
Positive
Mar 19, 2025

On March 18, 2025, Integer Holdings Corporation announced the closing of a $1 billion convertible senior notes offering, which was upsized due to strong investor demand. The transaction is expected to enhance the company’s capitalization structure by creating revolver capacity and reducing interest expenses, making it immediately accretive to 2025 adjusted earnings. The proceeds will be used to pay costs associated with capped call transactions, exchange a portion of existing notes, and repay outstanding borrowings. The offering reflects investor confidence in Integer’s strategy and financial strength, with the capped call transactions mitigating potential dilution of common stock.

Private Placements and FinancingBusiness Operations and Strategy
Integer Holdings Announces Major Credit Agreement Amendment
Neutral
Mar 12, 2025

On March 12, 2025, Integer Holdings Corporation announced a significant amendment to its credit agreement, allowing the issuance of convertible notes up to $1.5 billion and enabling bond hedge and capped call transactions. This move is part of a strategic financial restructuring, including the launch of a $750 million Convertible Senior Notes Offering due 2030, aimed at refinancing existing debt and potentially impacting the company’s stock market dynamics.

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Integer Holdings Reports Strong Q4 2024 Results and Growth Plans
Positive
Feb 20, 2025

Integer Holdings Corporation reported strong financial results for the fourth quarter and full year of 2024, with significant increases in sales and profits compared to 2023. The company anticipates continued growth in 2025, with sales expected to increase by 8% to 10% and expanding margins. Integer completed the acquisition of Precision Coating and signed an agreement to acquire VSi Parylene, enhancing its service offerings in differentiated and proprietary coating capabilities. These strategic moves are expected to positively impact Integer’s financial performance and strengthen its position in targeted growth markets.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.